Crohn’s disease

Share on facebook
Share on pinterest
Share on twitter
Share on email
Share on whatsapp

Treatment of Crohn’s Disease with Cannabis: An Observational Study


IMAJ – The Israel Medical Association Journal, 2011

Timna Naftali 1, Lihi Bar Lev, Doron Yablecovitch, Elisabeth Half, Fred M Konikoff

1Institute of Gastroenterology and Hepatology, Meir Medical Center, Kfar Saba affiliated with Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel.

The marijuana plant cannabis is known to have therapeutic effects, including improvement of inflammatory processes. However, no report of patients using cannabis for Crohn’s disease (CD) was ever published. This groundbreaking retrospective observational study in which 30 Crohn’s patients who participated in the study were interviewed, was conducted in collaboration with the Institute of Gastroenterology and Hepatology, Meir Medical Center. was the first to participate IBD cannabis clinical study. The aim of the study was to describe the effects of cannabis use among patients with Crohn’s disease. All patients reported a positive effect on their Crohn’s disease activity and on the symptoms that characterize the disease.

STUDY POPULATION: 30 patients with Crohn’s disease (26 males, mean age 36).

STUDY PRODUCT: Erez

RESULTS:

• The average duration of cannabis use was 2.14 years. In 14/30 of the patients, the duration of cannabis use was less than a year.

Overall improvement – Of the 30 patients, 21 improved significantly after cannabis treatment.

The Harvey Bradshaw index, an index for assessing the severity of Crohn’s disease, improved from an average of 14 to 7 (P <0.001).

Decrease in drug use – Consumption of conventional drugs has been significantly reduced.

• 15 patients underwent 19 surgeries in an average period of 9 years before cannabis use, but only 2 required surgery during an average period of 3 years of cannabis use.

• No significant side effects were observed.

FULL STUDY

Have you liked our facebook page?

Common Questions

Ordering Tikun Olam Products

Proudly leading the revolution for modern Cannabis treatment

Related Topics

SAFETY AND EFFICACY OF MEDICAL CANNABIS IN FIBROMYALGIA Journal of Clinical Medicine, 2019 Iftach Sagy MD PhD1,2, Lihi Bar-Lev Schleider MA2,3, Mahmoud Abu-Shakra MD4 and

Real Life Experience of Medical Cannabis Treatment in Autism: Analysis of Safety and Efficacy Scientific Reports, 2019 Lihi Bar-Lev Schleider 1,2, Raphael Mechoulam3, Naama Saban2,

Medical Cannabis in Parkinson Disease: Real-Life Patients’ ExperienceClinical Neuropharmacology, 2017 Yacov Balash1,2, Lihi Bar-Lev Schleider3, Amos D. Korczyn2, Herzel Shabtai1, Judith Knaani1, Alina Rosenberg4, Yehuda Baruch5, Ruth

Brief Report: Cannabidiol-Rich Cannabis in Children with Autism Spectrum Disorder and Severe Behavioral Problems—A Retrospective Feasibility Study J Autism Dev Disord, 2018 Adi Aran1 ·

whatsapp